Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracis Protective Antigen Protects against Anthrax Infection in Mice
Existing licensed anthrax vaccines are administered parenterally and require multiple doses to induce protective immunity. This requires trained personnel and is not the optimum route for stimulating a mucosal immune response. Microencapsulation of vaccine antigens offers a number of advantages over...
保存先:
| 出版年: | Infect Immun |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2002
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127835/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11895967/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.4.2022-2028.2002 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
